Case 12-2011: A 9-month-old boy with acute liver failure

New England Journal of Medicine

Volumn 364, Issue 16, 2011, Pages 1545-1556

  Fearing, Marsha Kay ^a,b   Israel, Esther J ^a,b   Sahai, Inderneel ^a,b   Rapalino, Otto ^a,b   Lisovsky, Mikhail ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACYLCARNITINE CARNITINE TRANSLOCASE; CARNITINE; CARRIER PROTEIN; CONTRAST MEDIUM; ELECTROLYTE; HEPATITIS B VACCINE; PARACETAMOL; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; SLC25A20 PROTEIN, HUMAN;

ACUTE LIVER FAILURE; AGITATION; ARTICLE; CARNITINE ACYLCARNITINE TRANSLOCASE DEFICIENCY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DIET RESTRICTION; DIET SUPPLEMENTATION; DIFFERENTIAL DIAGNOSIS; ENZYME DEFICIENCY; FATTY LIVER; FEVER; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPOTENSION; HYPOXEMIA; IMAGE ANALYSIS; INBORN ERROR OF METABOLISM; INFANT; IRRITABILITY; LABORATORY TEST; LETHARGY; LIVER BIOPSY; MALE; METABOLIC DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHINORRHEA; VIRAL GASTROENTERITIS; VOMITING; ABDOMEN; BIOPSY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ECHOGRAPHY; GENETICS; LIVER; NEWBORN; PATHOLOGY; RECESSIVE GENE;

ABDOMEN; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; FATTY LIVER; GENES, RECESSIVE; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; LIVER; LIVER FAILURE, ACUTE; MALE; MEMBRANE TRANSPORT PROTEINS; METABOLISM, INBORN ERRORS;

EID: 79955140404     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc1013928     Document Type: Article

References (42)

1. Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006;148:652-8.
2. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology 2008;47:1401-15. (Pubitemid 351547926)
3. Cochran JB, Losek JD. Acute liver failure in children. Pediatr Emerg Care 2007;23:129-35. (Pubitemid 46398947)
4. Narkewicz MR, Dell Olio D, Karpen SJ, et al. Pattern of diagnostic evaluation for the causes of pediatric acute liver failure: an opportunity for quality improvement. J Pediatr 2009;155(6):801.e1-806.e1.
5. Campo JV, McNabb J, Perel JM, Mazariegos GV, Hasegawa SL, Reyes J. Kavainduced fulminant hepatic failure. J Am Acad Child Adolesc Psychiatry 2002;41:631-2.
6. McKiernan SH, Bavister BD, Tasca RJ. Energy substrate requirements for in-vitro development of hamster 1-and 2-cell embryos to the blastocyst stage. Hum Reprod 1991;6:64-75.
7. Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997;26: Suppl 1:13-22. (Pubitemid 127777233)
8. Burt AD, Mutton A, Day CP. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 1998;15:246-58. (Pubitemid 28536758)
9. Badizadegan K, Perez-Atayde AR. Focal glycogenosis of the liver in disorders of ureagenesis: its occurrence and diagnostic significance. Hepatology 1997;26:365-73. (Pubitemid 27328314)
10. Portmann BC, Thompson RJ, Roberts EA, Paterson AC. Genetic and metabolic liver disease. In: Burt AD, Portmann BC, Ferrell LD, eds. MacSween's pathology of the liver. 5th ed. New York: Churchill Livingstone-Elsevier, 2006:199-326.
11. Boldrini R, Devito R, Biselli R, Filocamo M, Bosman C. Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy. Pathol Res Pract 2004;200:231-40. (Pubitemid 38950434)
12. Mahler H, Pasi A, Kramer JM, et al. Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med 1997;336:1142-8.
13. Luongo MA, Bjornson SS. The liver in ferrous sulfate poisoning; a report of three fatal cases in children and an experimental study. N Engl J Med 1954;251:995-9.
14. Scriver CR, Beaudet AL, Valle D, et al., eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001.
15. Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE. Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 2006;107:115-20.
16. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006;142 C: 77-85.
17. Korman SH, Gutman A, Brooks R, Sinnathamby T, Gregersen N, Andresen BS. Homozygosity for a severe novel medium-chain acyl-CoA dehydrogenase (MCAD) mutation IVS3-1G > C that leads to introduction of a premature termination codon by complete missplicing of the MCAD mRNA and is associated with phenotypic diversity ranging from sudden neonatal death to asymptomatic status. Mol Genet Metab 2004;82:121-9. (Pubitemid 38692549)
18. Yang Z, Lantz PE, Ibdah JA. Post-mortem analysis for two prevalent beta-oxidation mutations in sudden infant death. Pediatr Int 2007;49:883-7. (Pubitemid 350197139)
19. Fernandes J, Saudubray J-M, van den Berghe G, Walter JH, eds. Inborn metabolic diseases: diagnosis and treatment. 4th ed. New York: Springer, 2006.
20. Kaminaga T, Mano T, Ono J, Kusuoka H, Nakamura H, Nishimura T. Proton magnetic resonance spectroscopy of Sjögren-Larsson syndrome heterozygotes. Magn Reson Med 2001;45:1112-5.
21. Mano T, Ono J, Kaminaga T, et al. Proton MR spectroscopy of Sjögren-Larsson's syndrome. AJNR Am J Neuroradiol 1999;20:1671-3.
22. Sijens PE, Westerlaan HE, de Groot JC, et al. MR spectroscopy and diffusion tensor imaging of the brain in Sjögren-Larsson syndrome. Mol Genet Metab 2009;98:367-71.
23. Willemsen MA, Ijlst L, Steijlen PM, et al. Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain 2001;124:1426-37. (Pubitemid 32606103)
24. Willemsen MA, Van der Graaf M, Van der Knaap MS, et al. MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 2004;25:649-57. (Pubitemid 38541950)
25. Groenendaal F, Bianchi MC, Battini R, et al. Proton magnetic resonance spectroscopy (1H-MRS) of the cerebrum in two young infants with Zellweger syndrome. Neuropediatrics 2001;32:23-7. (Pubitemid 32290431)
26. Bruhn H, Kruse B, Korenke GC, et al. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 1992;16:335-44.
27. Weller S, Rosewich H, Gärtner J. Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients. J Inherit Metab Dis 2008 April 14 (Epub ahead of print).
28. Roomets E, Lundbom N, Pihko H, Heikkinen S, Tyni T. Lipids detected by brain MRS during coma caused by carnitine palmitoyltransferase 1 deficiency. Neurology 2006;67:1516-7. (Pubitemid 44632096)
29. Barker PB, Horská A. Neuroimaging in leukodystrophies. J Child Neurol 2004;19:559-70. (Pubitemid 39642369)
30. Stone JA, Castillo M. MR in a patient with Zellweger syndrome presenting without cortical or myelination abnormalities. AJNR Am J Neuroradiol 1998;19:1378-9. (Pubitemid 30418691)
31. Unay B, Kendirli T, Ataç K, Gül D, Akin R, Göķay E. Caudothalamic groove cysts in Zellweger syndrome. Clin Dysmorphol 2005;14:165-7. (Pubitemid 40896396)
32. Blau N, Duran M, Blaskovics ME, Gibson KM, eds. Physician's guide to the laboratory diagnosis of metabolic diseases. 2nd ed. New York: Springer, 2002.
33. Costa C, Costa JM, Slama A, et al. Mutational spectrum and DNA-based prenatal diagnosis in carnitine-acylcarnitine translocase deficiency. Mol Genet Metab 2003;78:68-73. (Pubitemid 36268743)
34. Rubio-Gozalbo ME, Bakker JA, Waterham HR, Wanders RJ. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects. Mol Aspects Med 2004;25:521-32. (Pubitemid 39195074)
35. Wilcken B. Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis 2010;33:501-6.
36. American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: toward a uniform screening panel and system - executive summary. Pediatrics 2006;117: S296-S307.
37. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization, 1968.
38. Therrell BL, Johnson A, Williams D. Status of newborn screening programs in the United States. Pediatrics 2006;117: S212-S252. (Pubitemid 46071311)
39. The changing moral focus of newborn screening: an ethical analysis by the President's Council on Bioethics. Washington, DC: President's Council on Bioethics, 2008. (http://bioethics.georgetown.edu/pcbe/reports/newborn- screening/Newborn%20Screening%20for%20 the%20web.pdf.)
40. Adamsbaum C, Pinton F, Rolland Y, Chiron C, Dulac O, Kalifa G. Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations. Pediatr Radiol 1996;26:759-62. (Pubitemid 26383692)
41. Yagishita A, Arai N, Tamagawa K, Oda M. Hemimegalencephaly: signal changes suggesting abnormal myelination on MRI. Neuroradiology 1998;40:734-8. (Pubitemid 28526108)
42. Lamont P, Sachinwalla T, Pamphlett R. Myelin in SIDS: assessment of development and damage using MRI. Pediatrics 1995;95:409-13.